Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum
Aging · 2026-02-13 · 18 (1) · 1494-1514
DOI: 10.18632/aging.206393 ↗At a glance
Journal article in Aging, published online on 2026-11-03. Written by Francesco Ricci and 7 co-authors. Institution: Non Invasive Brain Stimulation Unit, IRCCS Santa Lucia, Rome 00179, Italy. Major MEDLINE topics: Alzheimer Disease, Blood-Brain Barrier, Glucose, Brain. 56 references.
Topics: Demenz
Abstract (original language)
BACKGROUND: Within the ATN framework of Alzheimer's disease (AD), patients are classified according to the presence of amyloid pathology (A), tau pathology (T), and neurodegeneration (N). While the A⁺T⁺N⁺ profile is well characterized, the A⁺T⁻N⁺ subgroup remains less understood. This phenotype may reflect mechanisms distinct from tau-driven pathology, potentially involving other amyloid co-pathology such as blood-brain barrier (BBB) dysfunction. METHODS: We examined A⁺T⁻N⁺ and A⁺T⁺N⁺ patients within the AD continuum (ADc) and cognitively healthy controls. All participants underwent cerebrospinal fluid (CSF) biomarker assessment and 18F-FDG positron emission tomography (FDG-PET). The CSF/serum albumin quotient (QAlb) was used as an index of BBB integrity. Voxel-wise multiple regression analyses evaluated associations between regional glucose metabolism and CSF biomarkers, QAlb, demographics, cognitive status, ApoE genotype, and vascular risk factors (Hypertension, Diabetes, and Hypercholesterolemia). RESULTS: Both AD subgroups showed hypometabolism in temporoparietal Default Mode Network regions. In ADc and A⁺T⁺N⁺ patients, posterior metabolism correlated positively with p-tau and negatively with t-tau. In A⁺T⁻N⁺ individuals, posterior hypometabolism was negatively associated with QAlb and positively with Aβ₄₂. Only Hypertension correlated with metabolism, involving the anterior cingulate cortex in ADc and A⁺T⁺N⁺, but not A⁺T⁻N⁺. CONCLUSIONS: Within the AD continuum, A⁺T⁻N⁺ represent a subgroup of patients in whom FDG-PET metabolic dysfunctions appear to be associated with the coexistence of BBB dysfunction alongside amyloid pathology rather than tau-driven mechanisms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Non Invasive Brain Stimulation Unit, IRCCS Santa Lucia, Rome 00179, Italy.
- UOSD Centro Demenze, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome 00133, Italy.
- Human Physiology Unit, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara 44121, Italy.
- Department of Nuclear Medicine, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome 00133, Italy.
- IRCCS Neuromed, Pozzilli 86077, Italy.
Cite
APA
Ricci, F., Motta, C., Bonomi, C. G., Bernocchi, F., Poli, M., Koch, G., Chiaravalloti, A., & Martorana, A. (2026). Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum. Aging, 18(1), 1494-1514. https://doi.org/10.18632/aging.206393
Vancouver
Ricci F, Motta C, Bonomi CG, Bernocchi F, Poli M, Koch G, et al. Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum. Aging. 2026;18(1):1494-1514. doi:10.18632/aging.206393
BibTeX
@article{Ricci2026,
author = {Ricci, Francesco and Motta, Caterina and Bonomi, Chiara Giuseppina and Bernocchi, Francesca and Poli, Martina and Koch, Giacomo and Chiaravalloti, Agostino and Martorana, Alessandro},
title = {Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum},
journal = {Aging},
year = {2026},
volume = {18},
number = {1},
pages = {1494--1514},
doi = {10.18632/aging.206393}
}
EUVIMED